| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.998 | 0 | 0.998 | Antipruritic | 0.962 0.001 DBMET00450 | ||
| 0.996 | 0.001 | 0.996 | Androgen antagonist | 0.78 0.002 DBMET00450 | ||
| 0.996 | 0.002 | 0.996 | Toll-Like receptor 7 agonist | 0.987 0.003 DBMET00450 | ||
| 0.996 | 0.002 | 0.996 | Toll-Like receptor agonist | 0.987 0.003 DBMET00450 | ||
| 0.995 | 0.003 | 0.995 | Antiinflammatory | 0.995 0.003 DBMET00450 | ||
| 0.989 | 0 | 0.989 | Glucocorticoid agonist | 0.95 0 DBMET00450 | ||
| 0.982 | 0 | 0.982 | Arachidonic acid antagonist | 0.511 0 DBMET00450 | ||
| 0.981 | 0 | 0.981 | Corticosteroid-like | 0.954 0 DBMET00450 | ||
| 0.923 | 0 | 0.923 | Lipocortins synthesis agonist | 0.745 0 DBMET00450 | ||
| 0.857 | 0.001 | 0.913 | Glucocorticoid antagonist | 0.913 0.001 DBMET00450 | DBMET00450 | |
| 0.764 | 0.004 | 0.791 | Immunosuppressant | 0.791 0.004 DBMET00450 | DBMET00450 | |
| 0.755 | 0.002 | 0.755 | Aromatase inhibitor | 0.608 0.003 DBMET00450 | ||
| 0.741 | 0.004 | 0.965 | Hypoxia-inducible factor 1 alpha inhibitor | 0.965 0.002 DBMET00450 | DBMET00450 | |
| 0.632 | 0.001 | 0.945 | Androgen agonist | 0.945 0.001 DBMET00450 | DBMET00450 | |
| 0.587 | 0.002 | 0.587 | Mineralocorticoid receptor antagonist | 0.242 0.004 DBMET00450 | ||
| 0.601 | 0.031 | 0.747 | Transcription factor NF kappa B inhibitor | 0.747 0.016 DBMET00450 | DBMET00450 | |
| 0.494 | 0.006 | 0.649 | Interferon gamma antagonist | 0.649 0.002 DBMET00450 | DBMET00450 | |
| 0.49 | 0.004 | 0.644 | Interleukin 4 antagonist | 0.644 0.004 DBMET00450 | DBMET00450 | |
| 0.432 | 0.007 | 0.692 | NOS3 expression enhancer | 0.692 0.004 DBMET00450 | DBMET00450 | |
| 0.418 | 0.007 | 0.457 | Lipocortins synthesis antagonist | 0.457 0.005 DBMET00450 | DBMET00450 | |
| 0.395 | 0.026 | 0.547 | Nitric oxide antagonist | 0.547 0.013 DBMET00450 | DBMET00450 | |
| 0.336 | 0.004 | 0.403 | Interleukin 5 antagonist | 0.403 0.004 DBMET00450 | DBMET00450 | |
| 0.313 | 0.026 | 0.338 | Hepatoprotectant | 0.338 0.021 DBMET00450 | DBMET00450 | |
| 0.233 | 0.004 | 0.54 | Progesterone antagonist | 0.54 0.002 DBMET00450 | DBMET00450 | |
| 0.298 | 0.081 | 0.367 | Sodium/bile acid cotransporter inhibitor | 0.367 0.03 DBMET00450 | DBMET00450 | |
| 0.204 | 0.004 | 0.235 | Anabolic | 0.235 0.002 DBMET00450 | DBMET00450 | |
| 0.284 | 0.092 | 0.284 | Immunomodulator | 0.282 0.092 DBMET00450 | ||
| 0.175 | 0.046 | 0.677 | Cytokine production inhibitor | 0.677 0.003 DBMET00450 | DBMET00450 | |
| 0.107 | 0.006 | 0.11 | Nitric oxide donor | 0.11 0.005 DBMET00450 | DBMET00450 | |
| 0.093 | 0.004 | 0.115 | Progesterone agonist | 0.115 0.003 DBMET00450 | DBMET00450 | |
| 0.103 | 0.022 | 0.209 | T cell inhibitor | 0.209 0.007 DBMET00450 | DBMET00450 | |
| 0.193 | 0.119 | 0.315 | Antioxidant | 0.315 0.056 DBMET00450 | DBMET00450 | |
| 0.041 | 0.016 | 0.064 | RNA-directed RNA polymerase stimulant | 0.064 0.01 DBMET00450 | DBMET00450 | |
| 0.055 | 0.033 | 0.075 | Estrogen agonist | 0.075 0.024 DBMET00450 | DBMET00450 | |
| 0.106 | 0.085 | 0.131 | Estrogen antagonist | 0.131 0.037 DBMET00450 | DBMET00450 | |
| 0.048 | 0.031 | 0.053 | Microtubule stabilization | 0.053 0.024 DBMET00450 | DBMET00450 | |
| 0.141 | 0.131 | 0.212 | P-glycoprotein inhibitor | 0.212 0.057 DBMET00450 | DBMET00450 | |
| 0.094 | 0.093 | 0.157 | DNA polymerase I inhibitor | 0.157 0.045 DBMET00450 | DBMET00450 | |
| 0.005 | 0.005 | 0.028 | Transcortin receptor antagonist | 0.028 0.001 DBMET00450 | DBMET00450 | |
| 0.029 | 0.061 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.027 DBMET00450 | DBMET00450 | |
| 0.063 | 0.097 | 0.154 | Antineoplastic alkaloid | 0.154 0.027 DBMET00450 | DBMET00450 | |
| 0.048 | 0.089 | 0.105 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 DBMET00450 | DBMET00450 | |
| 0.09 | 0.147 | 0.204 | Thrombolytic | 0.204 0.05 DBMET00450 | DBMET00450 | |
| 0.08 | 0.149 | 0.141 | Lipid peroxidase inhibitor | 0.141 0.074 DBMET00450 | DBMET00450 | |
| 0.046 | 0.117 | 0.062 | Heme oxygenase stimulant | 0.062 0.042 DBMET00450 | DBMET00450 | |
| 0.012 | 0.093 | 0.06 | 5-Alpha-reductase inhibitor | 0.06 0.016 DBMET00450 | DBMET00450 | |
| 0.172 | 0.318 | 0.335 | Apoptosis agonist | 0.335 0.149 DBMET00450 | DBMET00450 | |
| 0.057 | 0.215 | 0.123 | Microtubule formation inhibitor | 0.123 0.057 DBMET00450 | DBMET00450 | |
| 0.025 | 0.184 | 0.068 | Glucose-6-phosphate translocase inhibitor | 0.068 0.017 DBMET00450 | DBMET00450 | |
| 0.021 | 0.221 | 0.075 | Aldosterone antagonist | 0.075 0.012 DBMET00450 | DBMET00450 | |
| 0.065 | 0.301 | 0.206 | Immunostimulant | 0.206 0.117 DBMET00450 | DBMET00450 | |
| 0.024 | 0.296 | 0.081 | Glycine receptor antagonist | 0.081 0.055 DBMET00450 | DBMET00450 | |
| 0.015 | 0.371 | 0.077 | Inducible nitric-oxide synthase inhibitor | 0.077 0.068 DBMET00450 | DBMET00450 | |
| 0.004 | 0.395 | 0.043 | Squalene synthetase inhibitor | 0.043 0.017 DBMET00450 | DBMET00450 | |
| 0.054 | 0.451 | 0.328 | DNA synthesis inhibitor | 0.328 0.035 DBMET00450 | DBMET00450 | |
| 0.044 | 0.582 | 0.242 | Antibacterial | 0.242 0.185 DBMET00450 | DBMET00450 | |
| 0.035 | 0.593 | 0.135 | Tumour necrosis factor antagonist | 0.135 0.12 DBMET00450 | DBMET00450 | |
| 0.052 | 0.629 | 0.46 | Cyclophilin D inhibitor | 0.46 0.063 DBMET00450 | DBMET00450 | |
| 0.008 | 0.886 | 0.235 | Angiogenesis inhibitor | 0.235 0.134 DBMET00450 | DBMET00450 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |